Suppr超能文献

脂联素水平可区分肥胖和非肥胖白人个体中的代谢健康与不健康状态。

Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals.

作者信息

Ahl Scott, Guenther Mitchell, Zhao Shi, James Roland, Marks Jacqueline, Szabo Aniko, Kidambi Srividya

机构信息

Department of Medicine (S.A., M.G., R.J., J.M., S.K.), and Institute of Health and Society (S.Z., A.S.), Medical College of Wisconsin, Milwaukee, Wisconsin 53226.

出版信息

J Clin Endocrinol Metab. 2015 Nov;100(11):4172-80. doi: 10.1210/jc.2015-2765. Epub 2015 Sep 24.

Abstract

CONTEXT

Adiponectin levels (ADPN) are lower in individuals with central obesity and cardiometabolic diseases. Conversely, studies have shown paradoxical hyperadiponectinemia (HA) in metabolically healthy obese (MHO) individuals of non-European descent. Moreover, individuals with higher sc to visceral adipose tissue (ie, higher peripheral adiposity) distribution have higher ADPNs. However, it is not known whether metabolically healthy individuals have predominantly peripheral adiposity along with higher ADPNs.

OBJECTIVE

This study aimed to evaluate the association of ADPN and adiposity distribution with metabolic health in white individuals.

DESIGN AND SETTING

This was a cross-sectional study of members of "Take Off Pounds Sensibly" weight loss club and their relatives.

PARTICIPANTS

We recruited 2486 (72% women, 61% obese) individuals. They were defined as metabolically healthy by absence of hypertension, diabetes, and dyslipidemia; and they were further classified into metabolically healthy nonobese (MHNO), metabolically unhealthy nonobese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Waist-to-hip ratios (WHRs) were used as markers of adiposity distribution. Insulin resistance was measured using homeostasis model assessment.

RESULTS

Among the four groups, MHNO had the lowest WHRs (higher peripheral adiposity) and highest ADPN, and MUO had highest WHRs (higher central adiposity) and lowest ADPN (P < .001). Among both nonobese and obese, metabolically healthy individuals had higher ADPN than metabolically unhealthy individuals (P < .05) after adjustment for age, sex, and body mass index. MHNO also had lower WHRs compared with MUNO (P < .01). Although WHRs were lower among MHO compared with MUO, the difference was not significant. In addition, nonobese and obese individuals with HA (defined using sex-specific cutoffs) had lower homeostasis model assessment and dyslipidemia compared with individuals without HA.

CONCLUSIONS

Higher ADPN and lower WHRs (higher peripheral adiposity) are associated with better metabolic health in both nonobese and obese white individuals. These results suggest that ADPN and peripheral adiposity play a key role in determining the metabolic health independent of body mass index.

摘要

背景

中心性肥胖和心血管代谢疾病患者的脂联素水平(ADPN)较低。相反,研究表明非欧洲血统的代谢健康肥胖(MHO)个体存在矛盾的高脂联素血症(HA)。此外,皮下脂肪与内脏脂肪组织比例较高(即外周肥胖程度较高)的个体ADPN水平也较高。然而,尚不清楚代谢健康的个体是否主要具有外周肥胖以及较高的ADPN水平。

目的

本研究旨在评估白种人中ADPN和肥胖分布与代谢健康之间的关联。

设计与地点

这是一项对“明智减重”减肥俱乐部成员及其亲属的横断面研究。

参与者

我们招募了2486名个体(72%为女性,61%为肥胖者)。他们被定义为代谢健康,即无高血压、糖尿病和血脂异常;并进一步分为代谢健康非肥胖(MHNO)、代谢不健康非肥胖(MUNO)、代谢健康肥胖(MHO)和代谢不健康肥胖(MUO)。腰臀比(WHR)用作肥胖分布的指标。使用稳态模型评估来测量胰岛素抵抗。

结果

在这四组中,MHNO的WHR最低(外周肥胖程度较高)且ADPN最高,而MUO的WHR最高(中心肥胖程度较高)且ADPN最低(P <.001)。在非肥胖和肥胖个体中,调整年龄、性别和体重指数后,代谢健康的个体比代谢不健康的个体具有更高的ADPN(P <.05)。与MUNO相比,MHNO的WHR也更低(P <.01)。尽管MHO的WHR低于MUO,但差异不显著。此外,与无HA的个体相比,有HA(使用性别特异性临界值定义)的非肥胖和肥胖个体的稳态模型评估和血脂异常情况更低。

结论

较高的ADPN和较低的WHR(外周肥胖程度较高)与非肥胖和肥胖白种人的更好代谢健康相关。这些结果表明,ADPN和外周肥胖在决定代谢健康方面起着关键作用,独立于体重指数。

相似文献

引用本文的文献

本文引用的文献

1
Adiposity distribution influences circulating adiponectin levels.脂肪分布影响循环脂联素水平。
Transl Res. 2014 Oct;164(4):270-7. doi: 10.1016/j.trsl.2014.04.008. Epub 2014 Apr 18.
4
Adipose tissue as an endocrine organ.脂肪组织作为一种内分泌器官。
Clin Liver Dis. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012.
7
Molecular pathways: adiponectin and leptin signaling in cancer.分子通路:脂联素和瘦素信号在癌症中的作用。
Clin Cancer Res. 2013 Apr 15;19(8):1926-32. doi: 10.1158/1078-0432.CCR-12-0930. Epub 2013 Jan 25.
9
Adiponectin: mechanistic insights and clinical implications.脂联素:作用机制及临床意义。
Diabetologia. 2012 Sep;55(9):2319-26. doi: 10.1007/s00125-012-2598-x. Epub 2012 Jun 12.
10
The role of adiponectin in cancer: a review of current evidence.脂联素在癌症中的作用:当前证据综述。
Endocr Rev. 2012 Aug;33(4):547-94. doi: 10.1210/er.2011-1015. Epub 2012 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验